Back to Search Start Over

Combinatorial targeting of Hippo-STRIPAK and PARP elicits synthetic lethality in gastrointestinal cancers

Authors :
An, Liwei
Cao, Zhifa
Nie, Pingping
Zhang, Hui
Tong, Zhenzhu
Chen, Fan
Tang, Yang
Han, Yi
Wang, Wenjia
Zhao, Zhangting
Zhao, Qingya
Yang, Yuqin
Xu, Yuanzhi
Fang, Gemin
Shi, Lei
Xu, Huixiong
Ma, Haiqing
Jiao, Shi
Zhou, Zhaocai
Source :
Journal of Clinical Investigation. May 1, 2022, Vol. 132 Issue 9
Publication Year :
2022

Abstract

The striatin-interacting phosphatase and kinase (STRIPAK) complexes integrate extracellular stimuli that result in intracellular activities. Previously, we discovered that STRIPAK is a key machinery responsible for loss of the Hippo tumor suppressor signal in cancer. Here, we identified the Hippo-STRIPAK complex as an essential player in the control of DNA double-stranded break (DSB) repair and genomic stability. Specifically, we found that the mammalian STE20-like protein kinases 1 and 2 (MST1/2), independent of classical Hippo signaling, directly phosphorylated zinc finger MYND type-containing 8 (ZMYND8) and hence resulted in the suppression of DNA repair in the nucleus. In response to genotoxic stress, the cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/STING) pathway was determined to relay nuclear DNA damage signals to the dynamic assembly of Hippo-STRIPAK via TANK-binding kinase 1-induced (TBK1-induced) structural stabilization of the suppressor of IKBKE 1- sarcolemma membrane-associated protein (SIKE1-SLMAP) arm. As such, we found that STRIPAK-mediated MST1/2 inactivation increased the DSB repair capacity of cancer cells and endowed these cells with resistance to radio- and chemotherapy and poly(ADP-ribose)polymerase (PARP) inhibition. Importantly, targeting the STRIPAK assembly with each of 3 distinct peptide inhibitors efficiently recovered the kinase activity of MST1/2 to suppress DNA repair and resensitize cancer cells to PARP inhibitors in both animal- and patient-derived tumor models. Overall, our findings not only uncover what we believe to be a previously unrecognized role for STRIPAK in modulating DSB repair but also provide translational implications of cotargeting STRIPAK and PARP for a new type of synthetic lethality anticancer therapy.<br />Introduction DNA double-stranded breaks (DSBs) constitute the most deleterious threat to genomic integrity, and the repair of DNA is essential for normal cell growth and animal development (1). Altered DNA [...]

Details

Language :
English
ISSN :
00219738
Volume :
132
Issue :
9
Database :
Gale General OneFile
Journal :
Journal of Clinical Investigation
Publication Type :
Academic Journal
Accession number :
edsgcl.703277219
Full Text :
https://doi.org/10.1172/JCI155468